What is a stock summary page? Click here for an overview.
Business Description
HealthCare Global Enterprises Ltd
ISIN : INE075I01017
Compare
Compare
Traded in other countries / regions
HCG.India IPO Date
2016-03-30Description
HealthCare Global Enterprises Ltd is an Indian company specializing in cancer care services. The company also operates fertility clinics, and multi-specialty hospitals providing cardiology, neurology, orthopedics, gastroenterology, urology, pulmonary, and critical care services. It operates under the Medical and Healthcare Services segment. The company's offerings include labs, diagnostic centers, robotic surgery, bone marrow transplantation, home health services, liver transplantation, surgical oncology, preventive oncology, and radiation oncology. The majority of the revenue is derived from the medical services offered to patients. The company derives the majority of its revenue from India.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.19 | |||||
| Equity-to-Asset | 0.28 | |||||
| Debt-to-Equity | 1.81 | |||||
| Debt-to-EBITDA | 3.91 | |||||
| Interest Coverage | 1.37 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 3.17 | |||||
| Beneish M-Score | -2.89 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 15.4 | |||||
| 3-Year EBITDA Growth Rate | 89.7 | |||||
| 3-Year FCF Growth Rate | -1.7 | |||||
| 3-Year Book Growth Rate | 2.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 66.63 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 14.86 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.22 | |||||
| 9-Day RSI | 54.18 | |||||
| 14-Day RSI | 57.73 | |||||
| 3-1 Month Momentum % | 8.35 | |||||
| 6-1 Month Momentum % | 26.49 | |||||
| 12-1 Month Momentum % | 49.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | |||||
| Quick Ratio | 0.84 | |||||
| Cash Ratio | 0.35 | |||||
| Days Inventory | 15.84 | |||||
| Days Sales Outstanding | 56.69 | |||||
| Days Payable | 104.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.6 | |||||
| Shareholder Yield % | -5.75 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 51.26 | |||||
| Operating Margin % | 8.31 | |||||
| Net Margin % | 2.76 | |||||
| FCF Margin % | 4.69 | |||||
| ROE % | 6.87 | |||||
| ROA % | 2.14 | |||||
| ROIC % | 6.45 | |||||
| 3-Year ROIIC % | 22.84 | |||||
| ROC (Joel Greenblatt) % | 12.26 | |||||
| ROCE % | 10.01 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 141.39 | |||||
| Forward PE Ratio | 74.91 | |||||
| PE Ratio without NRI | 149.32 | |||||
| Price-to-Owner-Earnings | 66.52 | |||||
| PEG Ratio | 7.58 | |||||
| PS Ratio | 3.9 | |||||
| PB Ratio | 9.47 | |||||
| Price-to-Tangible-Book | 12.92 | |||||
| Price-to-Free-Cash-Flow | 82.41 | |||||
| Price-to-Operating-Cash-Flow | 28.64 | |||||
| EV-to-EBIT | 46.05 | |||||
| EV-to-EBITDA | 23.05 | |||||
| EV-to-Revenue | 4.35 | |||||
| EV-to-FCF | 96.86 | |||||
| Price-to-GF-Value | 1.3 | |||||
| Price-to-Projected-FCF | 7.75 | |||||
| Price-to-Peter-Lynch-Fair-Value | 6.79 | |||||
| Price-to-Graham-Number | 9.2 | |||||
| Earnings Yield (Greenblatt) % | 2.16 | |||||
| FCF Yield % | 1.26 | |||||
| Forward Rate of Return (Yacktman) % | 20 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HealthCare Global Enterprises Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 21,099.98 | ||
| EPS (TTM) (₹) | 4.14 | ||
| Beta | 0.05 | ||
| 3-Year Sharpe Ratio | 0.97 | ||
| 3-Year Sortino Ratio | 2.06 | ||
| Volatility % | 22.69 | ||
| 14-Day RSI | 57.73 | ||
| 14-Day ATR (₹) | 18.834755 | ||
| 20-Day SMA (₹) | 551.9975 | ||
| 12-1 Month Momentum % | 49.72 | ||
| 52-Week Range (₹) | 330.65 - 601.95 | ||
| Shares Outstanding (Mil) | 139.42 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HealthCare Global Enterprises Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HealthCare Global Enterprises Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
HealthCare Global Enterprises Ltd Frequently Asked Questions
What is HealthCare Global Enterprises Ltd(NSE:HCG)'s stock price today?
The current price of NSE:HCG is ₹565.55. The 52 week high of NSE:HCG is ₹601.95 and 52 week low is ₹330.65.
When is next earnings date of HealthCare Global Enterprises Ltd(NSE:HCG)?
The next earnings date of HealthCare Global Enterprises Ltd(NSE:HCG) is 2025-05-29 Est..
Does HealthCare Global Enterprises Ltd(NSE:HCG) pay dividends? If so, how much?
HealthCare Global Enterprises Ltd(NSE:HCG) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers